Genomma Lab Internacional (GNMLF) News Today $0.72 0.00 (0.00%) As of 10/28/2026 Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartNews and Trends Genomma Lab Internacional Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call TranscriptOctober 22, 2026 | seekingalpha.comGenomma Lab Internacional Announces Results for the Third Quarter 2026October 21, 2026 | prnewswire.comGenomma Lab Internacional SAB de CV (GNMLF) Q2 2026 Earnings Call Highlights: Navigating Market ...July 25, 2026 | finance.yahoo.comGenomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q2 2026 Earnings Call TranscriptJuly 24, 2026 | seekingalpha.comGenomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q1 2026 Earnings Call TranscriptApril 23, 2026 | seekingalpha.comGenomma Lab Internacional Announces Results for the First Quarter 2026April 22, 2026 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. First Quarter 2026 Earnings Results Conference CallApril 13, 2026 | prnewswire.comGenomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q4 2025 Earnings Call TranscriptFebruary 26, 2026 | seekingalpha.comGenomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2025February 25, 2026 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2025 Earnings Results Conference CallJanuary 30, 2026 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENTDecember 23, 2025 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES FOURTEENTH DIVIDEND PAYMENTDecember 9, 2025 | prnewswire.comGenomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2025 Earnings Call TranscriptOctober 23, 2025 | seekingalpha.comGenomma Lab Internacional Announces Results for the Third Quarter 2025October 22, 2025 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Third Quarter 2025 Earnings Results Conference CallOctober 8, 2025 | prnewswire.comGenomma Lab Internacional Announces Results for the Second Quarter 2025July 23, 2025 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENTJune 23, 2025 | prnewswire.comGENOMMA LAB INTERNATIONAL INFORMS TOTAL PREPAYMENT OF "LAB 23" UNSECURED LOCAL BOND (CEBUR)June 12, 2025 | prnewswire.comGenomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bondJune 4, 2025 | prnewswire.comGenomma Lab Internacional Announces Results for the First Quarter 2025April 30, 2025 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference CallMarch 31, 2025 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENTMarch 6, 2025 | prnewswire.comGenomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024February 26, 2025 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2024 Earnings Results Conference CallFebruary 10, 2025 | prnewswire.comGenomma Lab Internacional Announces Results for the Third Quarter 2024October 23, 2024 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference CallOctober 4, 2024 | prnewswire.comGENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKETOctober 2, 2024 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENTSeptember 10, 2024 | prnewswire.comGenomma Lab Announces Strategic Bolt-On Acquisition of Four BrandsJuly 25, 2024 | prnewswire.comGenomma Lab Internacional Announces Results for the Second Quarter 2024July 24, 2024 | prnewswire.comGENOMMA LAB ANNOUNCES REFINANCING OF LONG-TERM LIABILITIES AND RELEASE OF REAL ESTATE COLLATERALJuly 22, 2024 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference CallJuly 2, 2024 | prnewswire.comGENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENTJune 13, 2024 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Third Quarter 2023 Earnings Results Conference CallOctober 4, 2023 | prnewswire.com Genomma Lab Internacional Media Mentions By Week Genomma Lab Internacional Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNMLF News Sentiment▼0.000.68▲Average Healthcare News Sentiment Genomma Lab Internacional News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNMLF Articles This Week▼10▲GNMLF Articles Average Week Genomma Lab Internacional Trends on MarketBeatThis week vs. last weekPage Views68-51% Get Genomma Lab Internacional News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMLF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGIFF News Today SXTPW News Today ABSCF News Today ACUR News Today ADTX News Today AGNPF News Today LBTSF News Today AZNCF News Today AVTBF News Today AVCNF News Today News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Genomma Lab Internacional dated 10/22/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredxIn 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't whole again un...USA Capital Gold | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...Decentralized Masters | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genomma Lab Internacional, S.A.B. de C.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genomma Lab Internacional With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
